| 臺大學術典藏 |
2021-03-18T08:54:16Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:16Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:15Z |
In-hospital implementation of evidence-based, medications is associated with improved survival, in diabetic patients with acute coronary, syndrome - Data from TSOC ACS-DM registry
|
Chen K.-C.; Yin W.-H.; Wu C.-C.; Chan S.-H.; YEN-WEN WU; Wang K.Y.; Chang K.-C.; Hwang J.-J.; Voon W.-C.; Hsieh I.-C.; Chong J.-T.; Lin W.-S.; Hsu C.-N.; Ueng K.-C.; Hsia C.-P.; Liu J.-C.; Yeh J.-S.; Mar G.-Y.; Shih J.-Y.; Kuo J.-Y.; Tsao H.-M.; Tseng W.-K.; Yang C.-H.; Chang C.-C.; Chiang C.-E.; Lei M.-H.; Lin J.-F.; Shyu K.-G. |
| 臺大學術典藏 |
2021-03-18T08:54:13Z |
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
|
Ho S.-K.; YEN-WEN WU; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:13Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; YEN-WEN WU; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:11Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; YEN-WEN WU; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C. |
| 臺大學術典藏 |
2021-03-18T08:54:11Z |
Relationship between body mass index, antidiabetic agents, and midterm mortality in patients with both type 2 diabetes mellitus and acute coronary syndrome
|
Jong C.-B.; Li H.-Y.; Pan S.-L.; Hsieh M.-Y.; Su F.-Y.; Chen K.-C.; Yin W.-H.; Chan S.-H.; YEN-WEN WU; Wang K.-Y.; Chang K.-C.; Hwang J.-J.; Wu C.-C. |
| 臺大學術典藏 |
2021-03-18T08:54:09Z |
Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Cheng Chang K.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:08Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; Wu C.-C.; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:07Z |
Reinforcement of patient education improved physicians’ adherence to guideline-recommended medical therapy after acute coronary syndrome
|
Lee C.-K.; Lai C.-L.; Lee M.-H.; Su F.-Y.; Yeh T.-S.; Cheng L.-Y.; Hsieh M.-Y.; YEN-WEN WU; Liu Y.-B.; Wu C.-C. |
| 臺大學術典藏 |
2021-03-18T08:54:05Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Ho S.-K.; YEN-WEN WU; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:05Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Wu J.-R.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:04Z |
Clinical feasibility of biofunctionalized magnetic nanoparticles for detecting multiple cardiac biomarkers in emergency chest pain patients
|
YEN-WEN WU; Yeh Y.-T.; Wu C.-C.; Huang C.-L.; Chang Y.-Y.; Wu C.-C. |
| 臺大學術典藏 |
2021-03-18T08:54:02Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; YEN-WEN WU; Hwang J.-J.; Lin J.-L. |
| 臺大學術典藏 |
2021-03-18T08:54:01Z |
Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease
|
YEN-WEN WU; Ho S.K.; Tseng W.-K.; Yeh H.-I.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:01Z |
Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease
|
Huang C.-C.; Chang M.-T.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Shyur L.-F.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:00Z |
Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions
|
Tsai H.-Y.; YEN-WEN WU; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W.; Yeh H.-I.; National Taiwan Biosignature Research Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:00Z |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li Y.-H.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; YEN-WEN WU; Hsieh I.-C.; Lin T.-H.; Sheu W.H.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T02:03:51Z |
Amplitude ultrasonic angiography-assisted diagnosis and management of cervical pregnancy
|
Sheu B.-C.; Wu C.-C.; Lee C.-N.; CHIA-TUNG SHUN; Lin C.-J.; Hsieh F.-J. |
| 臺大學術典藏 |
2021-03-10T08:55:41Z |
Arsenic exposure and glucose intolerance/insulin resistance in estrogen-deficient female mice
|
Huang C.-F.; Yang C.-Y.; Chan D.-C.; Wang C.-C.; Huang K.-H.; Wu C.-C.; KEH-SUNG TSAI; Yang R.-S.; Liu S.-H. |
| 臺大學術典藏 |
2021-03-05T06:05:51Z |
Dimethylarginine Dimethylaminohydrolase 1 Polymorphisms and Venous Intimal Hyperplasia in Hemodialysis Patients
|
Wu C.-C.; Hsieh M.-Y.; CHIH-KUO LEE; Chuang S.-Y.; Chung M.-Y.; Lin C.-C. |
| 臺大學術典藏 |
2021-03-05T06:05:51Z |
The impact of door-to-electrocardiogram time on door-to-balloon time after achieving the guideline-recommended target rate
|
CHIH-KUO LEE; Meng S.-W.; Lee M.-H.; Chen H.-C.; Wang C.-L.; Wang H.-N.; Liao M.-T.; Hsieh M.-Y.; Huang Y.-C.; Huang E.P.-C.; Wu C.-C. |
| 臺大學術典藏 |
2021-03-05T06:05:51Z |
Temporal distribution and biological determinants of thrombotic events after interventions for dialysis vascular access
|
Hsieh M.-Y.; CHIH-KUO LEE; Lo C.-M.; Chen C.-H.; Chuang S.-Y.; Wu C.-C. |
| 臺大學術典藏 |
2021-03-05T06:05:50Z |
Use of the Viabahn covered stent for the treatment of venous rupture during interventions of dysfunctional or thrombosed hemodialysis vascular access
|
CHIH-KUO LEE; Hsieh M.-C.; Luo C.-M.; Liao M.-T.; Hsieh M.-Y.; Wu C.-C. |
| 臺大學術典藏 |
2021-03-04T08:55:10Z |
Reinforcement of patient education improved physicians’ adherence to guideline-recommended medical therapy after acute coronary syndrome
|
CHIH-KUO LEE; Lai C.-L.; Lee M.-H.; Su F.-Y.; Yeh T.-S.; Cheng L.-Y.; Hsieh M.-Y.; Wu Y.-W.; Liu Y.-B.; Wu C.-C. |
